Rapid Infliximab Biosimilar Infusion in Children with Inflammatory Bowel Disease.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pediatric gastroenterology and nutrition"
DOI: 10.1097/mpg.0000000000003402
Abstract: OBJECTIVES Compare prevalence of infusion reaction (IR) between infliximab (IFX) and infliximab biosimilar (IFX-abda) at standard and rapid rates and measure the impact on health care cost in children with inflammatory bowel disease. METHODS Records… read more here.
Keywords: inflammatory bowel; infusion; ifx abda; children inflammatory ... See more keywords